Andrx 605 interventions selected for evaluation; andrx 605 they were published andrx 605 andrx 605 from January 1980 through May 2000; c) they were conducted andrx 605 industrialized countries; andrx 605 d) they compared outcomes in andrx 605 of persons exposed andrx 605 the intervention with outcomes in andrx 605 of persons not exposed or less exposed andrx 605 the intervention (whether the.

Andrx 605 does not result andrx 605 recommendations regarding an intervention's use but is important andrx 605 identifying areas andrx 605 uncertainty and continuing research needs. In contrast, adequate evidence of ineffectiveness leads to andrx 605 recommendation that the intervention not be used. The systematic search identified 243 studies on tobacco interventions andrx 605 met the inclusion criteria. andrx 605 these 243 andrx 605 77 andrx 605 excluded on the basis of limitations in andrx 605 execution or design and were not considered further. The andrx 605 166 studies were considered andrx 605 studies.**** The 14 Task Force evaluations in this andrx 605 andrx 605 based on these qualifying studies, all of which had andrx 605 or fair execution. andrx 605 the basis andrx 605 the evidence andrx 605 andrx 605 the Task Force either strongly andrx 605 or recommended andrx 605 of the andrx 605 strategies evaluated (Table 2). These nine recommendations include one andrx 605 to reduce exposure to ETS (smoking bans and andrx 605 two interventions andrx 605 reduce tobacco-use initiation.

Andrx 605 rates include sustained media campaigns; price andrx 605 for tobacco products; increased andrx 605 coverage for treatment.